Cargando…
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
Due to a lack of definitive treatment, many drugs were repurposed for Coronavirus disease (COVID-19) treatment; among them, corticosteroid is one. However, its benefit or harm while treating COVID-19 is not fully studied. Thus, we conducted this meta-analysis to assess the rationality on the use of...
Autores principales: | Budhathoki, Pravash, Shrestha, Dhan Bahadur, Rawal, Era, Khadka, Sitaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569091/ https://www.ncbi.nlm.nih.gov/pubmed/33103063 http://dx.doi.org/10.1007/s42399-020-00515-6 |
Ejemplares similares
-
Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020) -
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis()
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021) -
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2020) -
New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021) -
Diarrhea Is Associated with Increased Severity of Disease in COVID-19: Systemic Review and Metaanalysis
por: Ghimire, Subash, et al.
Publicado: (2021)